A detailed history of Abeille Asset Management Sa transactions in Abbott Laboratories stock. As of the latest transaction made, Abeille Asset Management Sa holds 221,712 shares of ABT stock, worth $25 Million. This represents 0.87% of its overall portfolio holdings.

Number of Shares
221,712
Previous 222,792 0.48%
Holding current value
$25 Million
Previous $21.6 Million 12.92%
% of portfolio
0.87%
Previous 0.84%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 20, 2023

SELL
$95.06 - $111.52 $102,664 - $120,441
-1,080 Reduced 0.48%
221,712 $24.3 Million
Q3 2022

Nov 14, 2022

SELL
$96.76 - $112.03 $650,904 - $753,625
-6,727 Reduced 2.93%
222,792 $21.6 Million
Q2 2022

Aug 04, 2022

SELL
$102.07 - $123.37 $482,791 - $583,540
-4,730 Reduced 2.02%
229,519 $24.9 Million
Q1 2022

May 13, 2022

BUY
$114.02 - $139.04 $26.7 Million - $32.6 Million
234,249 New
234,249 $27.7 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $197B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Abeille Asset Management Sa Portfolio

Follow Abeille Asset Management Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abeille Asset Management Sa, based on Form 13F filings with the SEC.

News

Stay updated on Abeille Asset Management Sa with notifications on news.